Spots Global Cancer Trial Database for bevacizumab+toripalimab+gemcitabine, adjuvant with toripalimab
Every month we try and update this database with for bevacizumab+toripalimab+gemcitabine, adjuvant with toripalimab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma | NCT05341193 | Nasopharyngeal ... | Bevacizumab+Tor... Bevacizumab+Tor... | 18 Years - 65 Years | Sun Yat-sen University | |
PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma | NCT05341193 | Nasopharyngeal ... | Bevacizumab+Tor... Bevacizumab+Tor... | 18 Years - 65 Years | Sun Yat-sen University |